Биопсия сторожевых лимфоузлов у пациентов с локальными формами меланомы кожи
Диссертация
Современные неинвазивные диагностические методы исследования, такие как УЗИ регионарных лимфатических узлов, прямая и непрямая лимфосцинтиграфия, КТ, МРТ, ПЭТ и др. характеризуются высокой частотой (до 30%) ложноотрицательных результатов в определении метастазов МК в регионарных лимфатических узлах. Поэтому удаление и гистологическое исследование регионарных лимфатических узлов остается наиболее… Читать ещё >
Содержание
- ГЛАВА I. ОБЗОР ЛИТЕРАТУРЫ
- 1. 1. Клинико-эпидемиологические особенности первичной меланомы кожи
- 1. 2. Методы диагностики метастазов первичной меланомы кожи в лимфатических узлах
- 1. 3. Особенности хирургического лечения первичной меланомы кожи
- 1. 4. История развития методики биопсии сторожевых лимфатических узлов
- 1. 5. Отбор пациентов для проведения биопсии сторожевых лимфатических узлов
- 1. 6. Особенности методики выполнения биопсии сторожевых лимфатических узлов
- 1. 7. Особенности морфологического исследования сторожевых лимфатических узлов
- ГЛАВА II. МАТЕРИАЛЫ И МЕТОДЫ ИССЛЕДОВАНИЯ
- 2. 1. Общая характеристика больных
- 2. 2. Неинвазивные диагностические исследования первичной опухоли и зон регионарного метастазирования
- 2. 2. 1. Ультразвуковой метод исследования
- 2. 2. 2. Радиоизотопный метод поиска сторожевых лимфатических узлов
- 2. 2. 3. Идентификация сторожевых лимфоузлов с применением системы детекции гамма излучения Gamma Finder II
- 2. 3. Хирургический этап лечения
- 2. 4. Плановое гистологическое исследование
- 2. 5. Статистический раздел работы
- ГЛАВА III. ДАННЫЕ СОБСТВЕННЫХ НАБЛЮДЕНИЙ
- ЗЛ Результаты ультразвукового исследования зон регионарного метастазирования при меланоме кожи
- 3. 2. Результаты поиска сторожевых лимфатических узлов с помощью непрямой лимфосцинтиграфии
- 3. 2. 1. Результаты поиска сторожевых лимфоузлов при меланоме кожи туловища
- 3. 2. 2. Результаты поиска сторожевых лимфоузлов при меланоме кожи нижних конечностей
- 3. 2. 3. Результаты поиска сторожевых лимфоузлов при меланоме кожи верхних конечностей
- 3. 3. Особенности хирургического лечения больных первичной меланомой кожи
- 3. 4. Результаты морфологического исследования сторожевых лимфатических узлов
- 3. 5. Влияние клинико-морфологических факторов на частоту обнаружения метастазов в сторожевых лимфатических узлах
- 3. 6. Определение факторов прогноза прогрессирования заболевания
- 3. 7. Выживаемость больных в зависимости от результатов биопсии сторожевых лимфатических узлов
- 3. 2. Результаты поиска сторожевых лимфатических узлов с помощью непрямой лимфосцинтиграфии
- ГЛАВА IV. ОБСУЖДЕНИЕ ПОЛУЧЕННЫХ РЕЗУЛЬТАТОВ
- ВЫВОДЫ
Список литературы
- Аллахвердян Г. С. Возможности ультразвуковой томографии при меланоме кожи: диагностика первичной опухоли и метастазов в регионарных лимфатических узлах. //Дисс. канд. мед. Наук, Москва, 2006.
- Аллахвердян Г. С., Чекалова М. А., Кокосадзе Н. В. Дооперационная оценка местного распространения первичной меланомы кожи ультразвуковым методом.//Ультразвук и функциональная диагностика, 2007, № 4, с. 238−239.
- Анисимов В.В. Меланома кожи (перспективы улучшения диагностики и лечения)// Дисс. в виде науч. докл. докт. мед. наук, Санкт-Петербург, 2000, 97с.
- Анисимов В.В. Содержание понятия «местный рецидив» после хирургического лечения злокачественной меланомы кожи// Вопросы онкологии. 1985.- Т.31- № 1. С 32−37
- Апатенко А.К., Вавилов A.M., Паршикова С. М., Персина И. С. Опухоли кожи. Паталого-анатомическая диагностика опухолей человека/ Под редакцией H.A. Краевского A.B. Смольянникова Д. С. Саркисова: В 2 т. М.: «Медицина». 1993. Т. 2.-С. 524−600.
- Ахметов И.Р. Место профилактической лимфаденэктомии в комплексном лечении меланомы кожи туловища и конечностей. Автореферат Дисс. Кмн. Уфа. 2005. стр 3
- Баженова А.П. Хирургическое лечение меланомы кожи// Хирургия. 1975. № 11. С. 25−30
- Барчук А. С., Показания к профилактической регионарной лимфаденэктомии у больных первичной меланомой кожи. Амбулаторная хирургия. 2001 № 1. С. 52.
- Барчук Л.С. Хирургическое лечение меланом / Практическая онкология: меланома 2001- № 3 4(8) — с.30−36.
- Березкин Д.П., Айрапетян М. Х., Барсегян B.C. Прогностические факторы, наиболее влияющие на выживаемость больных меланомой кожи//Клиника и лечение меланом кожи: Тез. Всесоюз. Симпозиума.-Л., 1990.-С.7−9.
- Вагнер Р. И. Анисимов В.В., Журавлев К.В. О показаниях к профилактической регионарной лимфаденэктомии при меланоме кожи I стадии
- Вагнер Р. И. Анисимов В.В. Показания к профилактической подмышечной лимфаденэктомии при меланоме кожи верхних конечностей// Вестник хирургии.- 1987. -№ 5. С.46−50
- Веснин А.Г., Филимонов С. И., Семенов И. И., Тришкин Б. А. Рентгенологическая и ультразвуковая диагностика меланобластом кожи и ее лимфогенных и гематогенных метастазов// Актуальные вопросы диагностики и лечения. Ленинград 1987. С. 57−72.
- Давыдов М.И., Аксель Е. М. Статистика злокачественных новообразований в России и странах СНГ в 2009 г. Вестник РОНЦ им. H.H. Блохина РАМН 2011- 22 (3): прил.1
- Двойрин В.В., Церковный Г. Ф., Гула В. И. и др. Заболеваемость населения СССР злокачественными новообразованиями (1981−1985гг)//Вопр. Онкол. 1988. — Т.34.-№ 11-С. 1301−1334.
- Демидов Л.В. Изучение факторов прогноза при меланоме кожи. Диссер на соискание ученой степени кандидата мед. Наук. 14.00.14. М., 1982., 188с
- Дробнер Г. И. Опыт лечения меланом кожи/ Клиника и лечение меланом кожи: Тез. Всесоюзного симпозиума- Л. 1990.- с.24−25.
- Журавлев К.В. Определение целесообразности профилактических лимфаденэктомий у больных меланомами кожи с повышенным риском регионарного метастазирования: Дисс. .канд. мед. наук: 14.00.14. С-Пб. 1992.22с.
- Заболотская Н.В. Новые технологии ультразвукового исследования в диагностике заболеваний молочных желез: Дисс.. докт. мед. наук: 14.00.19. -М., 2001.-327 с.
- Кондратьев В.Б. Термография// Общая онкология. Л: Медицина. 1989. С. 417−482.
- Кондратьев В.Б. Термография в онкологии// вопросы онкологии 1972. №З.С. 101−106
- Мерабишвили В.М. Географическая патология заболеваемости населения злокачественной меланомой кожи//Клиника и лечение меланом кожи: Тез. Всесоюз. Симпозиума.-JI., 1990.-С.50−51.
- Мордовцева В. К вопросу о диагностике меланомы кожи// Лечащий врач. 1999. № 5. С. 10−11.
- Мирошников М. М. Алитов В.И., Гершанович М. Л. Тепловидение в медицине. М.: Медицина 1981. С. 183
- Селюжинский И. В. Найденов Ю.Н. Некоторые вопросы диагностики и лечения меланомы кожи// Вестник дерматологии и венерологии. 1995. № 2. С. 59−62.
- Тарков A.C. Ретроперитонеопельвиоскопия в диагностике метастазов меланомы кожи в подвздошные лимфатические узлы // Дисс. Канд. Ленинград, 1988
- Трапезников H.H., Рабен A.C., Яворский В. В., Титинер Г. Б. Пигментные невусы и новообразования кожи.-М.:Медицина, 1976.-177с.
- Фрадкин С.З., Залуцкий И. В. Меланома кожи.-Минск.: Беларусь, 2000.-221с.
- Хасанов Ш. Р., Прогнозирование при основных клинических разновидностях меланомы кожи. Дисс. д-ра мед. наук :14.00.14 М. 1988
- Хачатурян Д.М. Влияние классического течения и морфологического меланина на частоту регионарных метастазов и прогноз заболевания// В кн. Всесоюзный съезд онкологов. Ташкент. 1979. С.532−533
- Чубарова Н.В. Возможности УЗД метастазов в лимфатические узлы шеи и внеорганных опухолей шеи: Автореф. дисс.. канд. мед. наук: 14.00.19.-М., 1988.-34с.
- Янушкевич В.Ю. Значение хромографии в оценки степени радикализма хирургических вмешательств при раке молочной железы. Автореф. Дисс. Кмн. Ленинград 1974
- Abdi EA, Terry T. Lymphography and computed tomography in lymph node metastases from malignant melanoma. Acta Radiol. 1988 Jul-Aug-29(4):391−394.
- Abu-Dalu J., Urea Z., Benbassat et al. Prophylactic regional lymph node excision in malignant melanoma// J. Isr. Med. Assoc. 1971. N3. P. 128.
- Acland KM, Healy C, Calonje E, et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection ofmicrometastases of primary cutaneous malignant melanoma. J Clin Oncol. 2001−19:2674−2678.
- Agnese DM, Abdessalam SF, Burak WE Jr, Magro CM, Pozderac RV, Walker MJ. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003−134(4):542−7.
- AJCC (American Joint Committee on Cancer) Cancer Staging Handbook: TNM Classification of Malignant Tumors, sixth edition. New York: SpringerVerlag 2002.
- Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, Aarsvold JN. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe. Semin Nucl Med. 2000−30:56−64.
- Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lymph-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996−223:217−224.
- Alex JC, Krag DN. Gamma probe guided lymph node localization in malignant melanoma. Surg Oncol. 1993−2:137−143.
- Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol. 1993−2:303−308.
- Armstrong B. K., Kicker A. Cutaneous melanoma|| Cancer Surveys. 1994. N 19−20. P. 219−240.
- Balch CM, The role of elective lymph node dissection in melanoma: Rationale, resalts and controversies. J Clin Oncol 6: 163−172, 1988
- Balch CM, Murray DR, Presant CA, Bartolucci A, the Southeastern Cancer Study Group. A randomized evaluation of adjunctive chemoimmunotherapy versus immunotherapy in patients with resected metastatic melanoma. Int. J Radiat Oncol Biol Phys 7: 38, 1981
- Balch CM, Soong SJ, Bartolucci AA, et al.: Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996−224:255−263.
- Balch C.M., Soong S.J., Gershenwald J. et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the AJCC melanoma staging system // J. Clin. Oncol. 2001. V. 19. P. 3622−3634
- Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. III. Prognostic factors in melanoma patients with lymph node metastases (stage II)/ Ann Surg 193: 377−388, 1981
- Bartolomei M, Testori A, Chinol M, et al. Sentinel node localization in cutaneous melanoma: lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping. Eur J Nucl Med. 1998−25:1489−1494.
- Belhocine T, Pierard G, De Labrassinne M, Lahaye T, Rigo P. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection. Oncologist. 2002−7:271−278.
- Bergqvist L, Strand S-E, Persson B. Particle sizing and biokinetics of interstitial lympho-scintigraphic agents. Semin Nucl Med. 1983−12:9−19.
- Bergqvist L, Stundberg R, Ryden S, Strand S-E. The «critical colloid dose» in studies of reticuloendothelial function. J Nucl Med. 1987−28:1424−1429.
- Bessoud B., Lassau N., Koscielny S., Longvert C., Avril M.F. Duvilard P. et al. High-frequency sonography and color Doppler in the management of pigmented skin lesions// Ultrasound Med. Biol. 2003. V. 29. N 6. P. 875−879.
- Bieligk SC, Ghossein R, Bhattachatya S, Coit DG. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol. 1999−6:232−240.
- Bleicher RJ, Essner R, Foshag LJ, Wanek LA, Morton DL. Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 2003 -21(7): 1326−31.
- Blum A., Schlagenhauff B., Stroebel W., Breuninger H., Rassner G., Garbe C. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the followup of patients withV
- Bostick P, Essner R, Sarantou T, et al. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. Am J Surg 1997−174:536−539.
- Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol. 1999−17:3238−3244.
- Breslow A. Thickness, cross-sectional areas and depth of invasion in prognosis of cutaneous melanoma//Ann. Surg.-1970.-Vol. 172.-P.902−908.
- Cabanas RM. An approach to the treatment of penile carcinoma. Cancer. 1977−39:456−466.
- Calabro A., Singletary S.F. andBalch C.M. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Are Surg. 124- 1051−1055, 1989.
- Carr I. Lymphatic metastasis. Cancer Metastasis Rev. 1983−2:307−317.
- Carlson G.W., Murray D., Greenlee R., Hestley A. The amount of metaststic melanoma is a sentinel lymph node: Does it have a prognostic significance. il J. of ASCO. 2001. V.20. P. l p. 356a
- Carlson G.W., Page AJ, Cohen C, et al. Regional recurrence after negative sentinel lymph node biopsy for melanoma. Ann Surg. 2008 Sep-248(3):378−86.
- Cascinelli N, Bombardieri E, Bufalino R, et al. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival. J Clin Oncol. 2006 Sep 20−24(27):4464−71.
- Cascinelli N, Morabito A, Santinami M, et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. Lancet 1998−351:793 6.
- Cascinelli N., Vaglini M., Nava M., Santinami C., Marolda R. et al. Prognosis of skin melanoma with regional node metastases (stage II)//J. Surg. Oncol. 1984. V.25. P. 240−247.
- Catalano O, Caraco C, Mozzillo N, et al. Locoregional spread of cutaneous melanoma: sonography findings. AJR2010 — 194:735 -745
- Cerfolio RJ, Ojha B, Bryant AS et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004- 78: 1017−1023.
- Clark W.H., Prom L., Bernardino E.A. et al. The histogenesis and biologic behavior of primary melanomas of the skin//Cancer Res.-1969.-Vol.29.-№ 3.-P.705−726.
- Clark PB, Soo V, Kraas J, Shen P, Levine EA. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Archives of Surgery.2006−141(3):284−288.
- Cochran AJ, Balda B-R, Starz H, et al. The Augsburg Consensus: techniques of lymphatic mapping, sentinel lymphadenectomy and completion' lymphadenectomy in cutaneous malignancies. Cancer. 2000−89:237−241.
- Cochran AJ. Histology of «borderline» and atypical cutaneous malignant melanoma. Pigment Cell Res 6:36−64, 1983
- Cochran AJ, Wen DR, Herschman HR. Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer 34: 159−163, 1984
- Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma: An immunohistological study. Am J Surg Pathol 12:612−618, 1988
- Cody HS III, Borgen PI. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol. 1999−8:85−91.
- Corsetti RL, Allen HM, Wanebo HJ. Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol 2000−7(6):456- 60.
- Crippa F, Leutner M, Belli F, et al. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med. 2000−41: 1491−1494.
- Daldrup-Link HE, Franzius C, Link TM et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 2001- 177: 229−236.
- Davis SD. CT evaluation for pulmonary metastases in patients with extrathoracic malignancy. Radiology 1991- 180: 1−12.
- Day C.I., Arthur J. et al. Malignant melanoma with positive nodes and relatively good prognosis//Cancer. 1981. V. 47. P. 955−962
- Dooms G., Hricak H., Mosoley M. et al. Characterization of lymphadenopathy by magnetic resonance relaxation times: preliminary results // Radiology. 1985. V. 155. P. 691−697.
- Eckelman WC, Steigman J, Paik CH. Radiopharmaceutical chemistry. In: Harbert JC, Eckelman WC, Neumann RD, eds. Nuclear Medicine: Diagnosis and Therapy. New York, NY: Thieme Medical Publishers- 1996:213−265.
- Eshima D, Fauconnier T, Eshima L, Thornback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. SeminNul Med. 2000−30:25−32.
- Ell PJ. A revolution in surgical oncology: sentinel lymph node biopsy. In: Proceedings of the continuing education courses of the SNM- 2001- Toronto, Ontario, Canada: 72−79.
- Essner R. The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma. Semin Oncol 1997−24(I Suppl 4):S8-S10.
- Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999−5:442A9.
- Faries MB, Essner R, Foshag L, Bilchik A, Zogakis T, Morton D. Lymph flow decreases with age and correlates with nonsentinel node metastasis and poor survival in stage III melanoma. Proc Am Assoc Cancer Res 2006:47.Abstract
- Faries MB, Wanek LA, Elashoff D, Wright BE, Morton DL. Predictors of occult nodal metastasis in patients with thin melanoma. Arch Surg. 2010 Feb-145(2):137−42.
- Fee HJ, Robinson DS, Sample WF, Graham LS, Holmes EC, Morton DL. The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery 1978−84(5):626−32
- Feinmesser R., Freedman L., Noyek A.M. et al. Metastatic neck diseas: a' clinical (radiographic) patologic correlative stady // Arch. Otolaryngol. Head &Neck Surg. 1987. V. 113. P. 1307−1310.
- Ferrucci JT. Liver tumor imaging: current concepts. AJR Am J Roentgenol 1990- 155: 473−484.
- Fink AM, Holle-Robatsch S, Herzog N, et al. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II. Melanoma Res. 2004−14:141−145.
- Fornage B.D., McGavran M.H., Duvic M., Waldron C.A. Imaging of the skin with 20-MHz US//Radiology. 1993. V. 189. N 1. P. 69−76.
- Friedman R.J., Rigel D.S., Kopf A.W. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin//Cancer (Philad.)-1985 .-Vol.35.-P. 130−151.
- Gershenwald JE, Andtbacka RHI, Prieto VG, Johnson MM, Diwan AH, Lee JE, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008−26:4296−303.
- Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. JClin Oncol 1998- 16:2253A60.
- Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann Surg Oncol 2000−7(2): 160−5.
- Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999−17:976−983.
- Gershenwald JE, Tseng CH, Thompson W, et al. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery. 1998−124:203−210.
- Gervasoni JE, Jr., Sbayi S, Cady B: Role of lymphadenectomy in surgical treatment of solid tumors: An update on the clinical data. Ann Surg Oncol 2007−14:2443−2462.
- Ghanem N, Altehoefer C, Hogerle S et al. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Eur J Radiol 2005- 54: 264−270.
- Gibbs JF, Huang PP, Zhang PJ, et al. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol 1999−6:699−704.
- Giovagnorio F., Andreoli C., De Cicco M.L. Color Doppler sonography of focal lesion of the skin and subcutaneous tissue//J. Ultrasound Med. 1999. V. 18. P. 89−93.
- Goldfarb LR, Alazraki NP, Eshima D, Eshima LA, Herda SC, Haikar RK. Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration ofTc-99m sulfur colloid. Radiology. 1998−208:505−509.
- Goldsmith H.S., Shan Jatin P., Kim Dong H. Prognostic significance of lymph node dissection in treatment of malignant melanoma//Cancer. 1970. V. 26. N3. P. 606−609.
- Goscin C, Glass LF, Messina JL. Pathologic examination of the sentinel lymph node in melanoma. Surg Oncol Clin North Am. 1999−8:427−434.
- Greetzman W., Chembirek H., Hajek P. et al. Sonographische Halsanatomie und Betendung beim Lymphkotenestaging von Kopf-HalsMalignomen. Stuttgart: Thieme Verlag, 1987. -146s.
- Gritters LS, Francis IR, Zasadny KR, Wahl RL. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 1993- 34: 1420−1427.
- Gyorki DE, Busam K, Panageas K, Brady MS, Coit DG. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol 2003−10(4):403−7.
- Habal N, Giuliano AE, Morton DL. The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer. Semin Oncol 2001−28:41−52.
- Hafner J, Schmid MH, KempfW, et al. Baseline staging in cutaneous malignant melanoma. Br J Dermatol. 2004−150:677−686.
- Halpern BS, Schiepers C, Weber WA et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 2005- 128: 2289−2297.
- Handley WS. The pathology of melanotic growth in relation to their operative treatment. Lancet. 1907−1:996.
- Harland C.C., Bamber J.C., Gusterson B.A., Mortimer P. S. High frequency, high resolution B-scan ultrasound in the assessment of skin tumors//Br. J. Dermatol. 1993. V. 128. N5. P.525−532
- Havenga K, Cobben DC, Oyen WJ, et al. Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol. 2003−29:662−664.
- Hawkins WG, Busam KJ, Ben-Porat L, Panageas KS, Coit DG, Gyorki DE, Linehan DC, Brady MS. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. AnnSurg Oncol 2005−12(3):207−13.
- Heaston DK, Putman CE, Rodan BA et al. Solitary pulmonary metastases in highrisk melanoma patients: a prospective comparison of conventional and computed tomography. AJR Am J Roentgenol 1983- 141: 169−174.
- Heller R, Becker J, Wasselle J. Detection of submicroscopic lymph node metastases in patients with melanoma. Arc Surg 126: 1455−1460, 1991
- Hill AD, Tran KN, Yeung H, Yeh SD, Borgen PI, Cody HS III. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. J Am Coll Surg. 1999−188:377−381.
- Holder WD Jr, White RL Jr, Zuger JH et al. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998- 227: 764−769.
- Holmes E, Moseley H, Morton D, Clark W, Robinson D, Urist M. A rational approach to the surgical management of melanoma. Ann Surg 1977- 186(4):481−90.
- Iscovich L.M. Malignant melanoma. Comments on epidemiology// Quiron.-1979.-V. 10.-№ 1 .-P. 15−17.
- Jaffer S., Zakowski M. Fine-needle aspiration biopsy of axillary lymph nodes // Diagn. Cytopathol. 2002. V. 26. N 2. P. 69−74
- Jemal A., Murray T., Samuels A. et al. Cancer statistics 2003//CA Cancer J. Clin. 2003. V. 53. P. 5−26.
- Jones W.M., Williams W.J., Roberts M.M. et al. Malignant melanoma of the skin: prognostic value of clinical features and the role of treatment in 111 cases. Br.I.Cancer. 22., P.437−451, 1968
- Kalady MF, White RR, Johnson JL, Tyler DS, Seigler HF. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. Ann Surg 2003−238(4):528−35.
- Kammula US, Ghossein R, Bhattacharya S, Coit DG. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction-staged sentinel lymph nodes from melanoma patients. J Clin Oncol 2004−22:3989−3996.
- Karakousis GC, Gimotty PA, Botbyl JD, Kesmodel SB, Elder DE, Elenitsas R, Ming ME, Guerry D, Fraker DL, Czerniecki BJ, et al. Predictors of regional nodal disease in patients with thin melanomas. Ann Surg Oncol 2006- 13(4):533—41.
- Karakousis C., Seddinq M.K., Moore R. Prognostic value of lymph node dissection in malignant melanoma//Arch. Surg. 1980. V. l 15 P. 719−722.
- Karaman G.C., Karaman C.Z., Sendur N., Akdilli A., Basak S., Savk E.B. Power Doppler ultrasonography for the evaluation of skin tumors other than malignant melanoma // Eur. Radiol. 2001. V. 11. N 7. P. 1111 -1116.
- Kesmodel SB, Karakousis GC, Botbyl JD, Canter RJ, Lewis RT, Wahl PM, Terhune KP, Alavi A, Elder DE, Ming ME, et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 2005−12(6):449−52
- Kokoska MS, Olson G, Kelemen PR, et al. The use of lymphoscintigraphy and PET in the management of head and neck melanoma. Otolaryngol Head Neck Surg. 2001−125:213−220.
- Koopal SA, Tiebosch AT, Albertus TD, et al. Frozen section analysis of sentinel lymph nodes in melanoma patients. Cancer 2000−89:1720−1725.
- Kostrubiak I, Whitley NO, Aisner J et al. The use of computed body tomography in malignant melanoma. JAMA 1988- 259: 2896−2897.
- Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995−130:654−658.
- Krag D, Weaver D, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993−2:335−340.
- Lardinois D, Weder W, Hany TF et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003- 348: 2500−2507.
- Lee J.K.T., Heiken J.P., Ling D. et al. MRI of abdominal and pelvic' lymphadenopathy//Radiology. 1984. V. 153. P. 181−188.
- Lee Y-T.M. Loco-regional recurrent melanoma// Cancer Treat. Revs. 1980. V. 7N1. P.59−72/
- Leicher-Durber A., Bliever R., Durber C. et al. Halslymphknotenmetastasen: Histologisch kontrollierter Vergleich von Palpation, Sonographie und Computertomographie // Fortschr. Rontgenstr. 1990. V. 153. P. 575−579
- Leong SP, Achtem TA, Habib FA, et al. Discordancy between clinical predictions versus lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma. Arch Dermatol. 1999−135:1472−1476.
- Leong SP, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997−132:666−673.
- Limouris GS, Voliotopoulos V, Kondi Paphiti A, Stavraka A, Vlahos L. Two phase scintigraphic mapping of lymphatic drainage in cutaneous melanomausing 99mTc-sulfur microcolloid/99mTc antimelanoma antibody. Anticancer Res 1997−17:1667−1669.
- Lohnert J.D., Bongartz G., Wernecke K., Peters P.E., Macher E., Brocker E.B. Sensitivity and specificity of sonographic diagnosis of the lymph nodes in malignant melanoma // Radiologe. 1988. V. 28. N 7. P. 317−319
- Longo MI, Lazaro P, Bueno C, Carreras JL, Montz R. Fluorodeoxyglucosepositron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients. Dermatol Surg. 2003−29:245−248.
- Lowe JB, Hurst E, Moley JF, Cornelius LA. Sentinel lymph node biopsy in patients with thin melanoma. Arch Dermatol 2003−139(5):617−21.
- Makela P.J., Leminen A., Kaariainen M., Lehtovirta P. Pretreatment sonographic evaluation of inguinal lymph nodes in patients with vulvar malignancy // J. Ultrasound Med. 1993. V. 12. N 5. P. 255−258.
- Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001−42:1198−1215.
- Massi D, Franchi A, Borgognoni L, et al. Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression. Cancer 1999−85(5): 1067−76.
- Maubec E, Lumbroso J, Masson F, et al. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm. Melanoma Research. 2007−17(3): 147—154.
- McCarthy WH, Shaw HM, Milton GW. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg Gyn Obstet 161: 575−580, 1985
- McCune WS, Letterman GS: Malignant melanoma- ten-year results following excision and regional gland resection. Ann Surg 1955- 141:901−909. Journal of Surgical Oncology
- McMasters KM, Chao C, Wong SL, Wrightson WR, Ross MI, Reintgen DS, Noyes RD, Cerrito PB, Edwards MJ. Interval sentinel lymph nodes in melanoma. Arch Surg 2002−137(5):543−7.
- McMasters K, Reintgen D, Ross M, Wong S, Gershenwald J, Krag D, Noyes D, Viar V, Cerrito P, Edwards M. Sentinel lymph node biopsy for melanoma: How many radioactive nodes should be removed? Ann Surg Oncol 2001−8(3): 192−7.
- McNeer G., Das Gupta T.K.|| Prognosis in malignant melanoma|| Surgery, 1964. Vol 56, h.512−518.
- Messina JL, Glass LF, Cruse CW, Berman C, Ku NK, Reintgen DS. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol. 1999−23:686−690.
- Messina JL, Glass F. Pathologic examination of the sentinel node. J Fla Med Assoc. 1997−84:153−156.
- Moehrle M., Blum A., Rassner G., Juenger M. Lymph node metastases of cutaneous melanoma: diagnosis by B-scan and color Doppler sonography// J. Am. Acad. Dermatol. 1999. V. 41. N 5. Pt. 1. P. 703−709.
- Moghimi SM, Patel HM. Differential properties of organ-specific serum opsonins for liver and spleen macrophages. Biochim Biophys Acta. 1989−984:379−383.
- Moghimi SM, Hawley AE, Christy NM, Gray T, Ilium L, Davis SS. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett. 1994−344:25−30.
- Morton D.L., Essner R., Kirkwood J.M., Wollman R.C. Malignant Melanoma// Cancer Medicine/ Ed.: Bast R.C., Kufe D.W., Pollock R.E., Weichselbaum R.R., Holland J.F., Frei E., Gansler T.S. Am. Cancer Society. BCDecker Inc. Hamilton. London. 2000. p.2467
- Morton DL. Immunologic and immunotherapeutic studies: Human melanomas. In: Immunologic Aspects of Neoplasia: A Rational Basis for Immunotherapy. Am Int Med 74: 591−595, 1971.
- Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg 1999−230: 453A65.
- Morton DL, Thompson JF, Cochran AJ, et al. Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I)i n clinical stage I melanoma abstract 7500. J Clin Oncol 2005−23: 710S.
- Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006−355:1307−17.
- Morton DL, Wen DR, Foshag LJ, et al. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early stage melanoma of the head and neck. J Clin Oncol 1993- 11:1751 -1756.
- Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992−127:392−399.
- Murray DR, Carlson GW, Greenlee R, et al. Surgical management of malignant melanoma using dynamic lymphoscintigraphy and gamma-probe guided sentinel lymph node biopsy: the Emory experience. Ann Surg 2000−86:763−767.
- Nambiar S, Mirmohammadsadegh A, Doroudi R, et al. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays. Arch Dermatol. 2005−141:165−173.
- Naruns PL, Nizze J A, Cochran A J, et al. Recurrence potential of thin primary melanomas. Cancer 1986−57(3):545−8.
- Nazarian L.N., Alexander A.A., Kurtz A.B. et al. Superficial melanoma metastases: appearances on gray-scale and color Doppler sonography // Am. J. Rentgen. 1998. V. 170. P. 459−463.
- Norman J, Cruse CW, Espinosa C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg. 1991−162:43237.
- Oliveira Filho RS, Ferreira LM, Biasi LJ, Enokihara MM, Paiva GR, Wagner J. Vertical growth phase and positive sentinel node in thin melanoma. Braz J Med Biol Res 2003−36(3):347−50.
- Paley MR, Ros PR. Hepatic metastases. Radiol Clin North Am 1998- 36: 349−363.
- Palmieri G, Ascierto PA, Cossu A, et al. Detection of occult melanoma cells in paraffin-embedded histological negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol. 2001−19:1437−1443.
- Paquet P, Hustinx R, Rigo P, Pierard GE. Malignant melanoma staging using whole-body positron emission tomography. Melanoma Res 1998- 8: 59−62.
- Partsch B., Binder M., Puspok-Schwarz M., Wolff K., Pehamberger H. Limitations of high frequency ultrasound in determining the invasiveness of cutaneous malignant melanoma // Melanoma Res. 1996. V. 6. P. 395−398.
- Pawlik TM, Ross MI, Prieto VG, Ballo MT, Johnson MM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer 2006−106(4):900−6.
- Perzik S.L., Baum R.K. Individualization in the management of melanoma: A review of 164 concecutive cases. Ann. Surg. 35. 177−180., 1969.
- Pringle JH. A method of operation in cases of melanotic tumours of the skin. Edinb Med J. 1908−23:496.
- Puleo CA, Messina JL, Riker AI, Glass LF, Nelson C, Cruse CW, Johnson TM, Sondak VK. Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control 2005−12(4): 230−5.
- Quan VW, Iagaru A, Conti PS. Sentinel lymph node imaging and 18F-FDG PET in the staging of melanoma abstract. J Nucl Med. 2005−46(suppl 2):240P.
- Quagliana J, Tranum B, Neidhardt J, Gagliano R for the SWOG. Adjuvant chemotherapy with BCNU, Hydrea and DTIC (BHD) with or without immunotherapy (BCG) in high risk melanoma patients. Proc ASCO 21:399 (C 316), 1980
- Rajewsky M. Molecular and cellular mechanisms of chemical cancerogenesis. EORTC Melanoma Coop. Group, Macher Z, Meetin, Munster 28.4.1984
- Ranieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ 3rd. The prognostic importance of sentinel lymph node biopsy in thin melanoma. Ann Surg Oncol 2006−13(7):927−32.
- Reali U. M., Santucci M., Paoli G., Chiarugi C. The use of high4 resolution ultrasound in preoperative evaluation of cutaneous malignant melanoma thickness // Tumori. 1989. V. 75. N 5. P. 452−455.
- Reinhardt MJ, Joe AY, Jaeger U et al. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 2006- 24: 1178— 1187.
- Reintgen D., Albertini J., Berman C., Cruse W.C., Fenske N. et al. Accurate Nodal Staging of Malignant Melanoma// Cancer Cont. J. 1995. V. 2. N5.
- Reintgen D, Balch CM, Kirkwood J, et al. Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997−225:1−14.
- Reintgen D., Cruse W.C., Wells K, et al. The olderly progression melanoma nodal metastases. AnnSurg. 1994- 220: 759−767
- Rinne D, Baum RP, Hor G, Kaufmann R. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positronemission tomography: results of a prospective study of 100 patients. Cancer 1998- 82: 1664−1671.
- Roozendaal GK, De Vries JDH, Van Poll D, et al. Sentinel nodes outside lymph node basins in melanoma patients. Br J Surg. 2000−88:305−308.
- Ross M. Sentinel node mapping for early-stage melanoma. In: Perry MC, ed. Educational Book. Alexandria, VA: ASCO- 1997: 326−330
- Rossi C.R., Scagnet B., Vecchiato A., Mocellin S., Pilati P., Foetto M., Zavagno G. et al. Sentinel node biopsy and ultrasound scanning in cutaneous melanoma: clinical and technical considerations// Eur. J. Cancer. 2000. V. 36. N 7. P. 895−900
- Schafer A, Herbst RA, Beiteke U, et al. Sentinel lymph node excision (SLNE) and positron emission tomography in the staging of stage I-II melanoma1 patients. Hautarzt. 2003−54:440−447.
- Schlag P.M. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided? // Oncologist. 1998. V. 3. N 5. P. VI-VII.
- Schmid-Wendtner MH, Baumert J, Eberle J, et al. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977−98. Br J Dermatol 2003−149(4):788−93.
- Scoggins CR, Bowen AL, Martin RC 2nd, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, Hagendoorn L, McMasters KM. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. Arch Surg. 2010 Jul- 145(7):622−7.
- Scoggins C.R.- Chagpar A.B.- Robert CG Martin- Kelly M McMasters. Should Sentinel Lymph-Node Biopsy Be Used Routinely for Staging Melanoma and Breast Cancers? Nat Clin Pract Oncol. 2005- 2(9): 448−455.1. S"
- Seigler HF. Immunotherapy of melanoma. In: Seigler HF (ed.), Clinical Management of melanoma. Developments in Oncology 5. Den Haag: Martinus Nijhoff, 1982, 503−513
- Serrone L., Solivetti F.M., Thorel M.F., Eibenschutz L., Donati P., Catricala C. High frequency ultrasound in the preoperative staging of primary melanoma: a statistical analysis // Melanoma Res. 2002. V. 12. N 3. P. 287−290.
- Shivers SC, Wang X, Li W, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA. 1998−280:1410−1415.
- Singh B, Ezziddin S, Palmedo H, et al. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma. Melanoma Research. 2008−18(5):346−352.
- Steinert HC, Huch Boni RA, Buck A et al. Malignant melanoma: staging with whole-body positron emission tomography and 2-F-18.-fluoro-2-deoxy-Dglucose. Radiology 1995- 195: 705−709.
- Stitzenberg KB, Groben PA, Stern SL, Thomas NE, Hensing TA, Sansbury LB, Ollila DW. Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm). Ann Surg Oncol 2004- 11(10):900−6.
- Stojadinovic A, Allen PJ, Clary BM, et al. Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann Surg 2002−235:92−98.
- Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg 2002−184(4):350−2.
- Su LD, Fullen DR, Lowe L, Wang TS, Schwartz JL, Cimmino VM, Sondak VK, Johnson TM. Desmoplastic and neurotropic melanoma. Cancer 2004- 100(3):598−604.
- Swetter SM, Carroll LA, Johnson DL, Segall GM. Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients. Ann Surg Oncol 2002- 9: 646−653
- Testori A, De Salvo GL, Montesco MC, et al. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol. 2009 Jul- 16(7):2018−27. Epub 2009 Jan 9.
- Thompson JF, McCarthy WH, Bosch CMJ. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995−5:255−260.
- Thompson JF, Uren RF. Teaching points on lymphatic mapping for melanoma from the Sydney Melanoma Unit. Semin Oncol 2004−31(3):349−56.
- Tripodi D, Parks LC, Brugmans J. Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer. N Engl J Med 289: 354−357, 1973
- Tsioulias G.J., Boasberg P.D., O’Day S.J. Salvage Metastasectomy Improves Survival in Stage IV melanoma patients treated with concurrentbiochemotherpy|| J. of ASCO. 2001/ - V. 20, P.l.-p.361a
- Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node. groups, defining lymphatic channels and locating the sentinel node. J Nucl Med. 1993−34:1435−1440.
- Uren RF, Howman-Giles RB, Thompson JF, Roberts J, Bernard E. Variability of cutaneous lymphatic flow rates in melanoma patients. Melanoma Res. 1998- 8:279−282.
- Uren RF, Thompson JF, Howman-Giles R, Chung DK. The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma. Surg Oncol Clin N Am 2006−15(2):285−300.
- Van den Brekel M.W., Casteliging LA., Croll G.A. et al. Magnetic resonans imaging US. Palpation of cervical lymph node metastasis // Arch. Otolaryngol. Head&Neck Surg. 1991. V. 117. P. 666−673.
- Van den Brekel M.W., Pameijer F.A., Koops W., Hilgers F.J., Kroon B.B., Balm A.J. Computed tomography for the detection of neck node metastases in melanoma patients // Eur. J. Surg. Oncol. 1998. V. 24. N 1. P. 51−54.
- Varella AD, Bandiera DC, de Amorin AR, Calvis LA, Santos JO, Escaleira N, Centil F. Treatment of disseminated malignant melanoma with high dose oral BCG. Cancer, 48: 1353−1362, 1981
- Vereecken P, Laporte M, Petein M, Steels E, Heenen M. Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients. J Eur Acad Dermatol Venereol. 2005−19:66−73.
- Veronesi U, Adamus J, Aubert C. (WHO-Melanoma Study Group) et al. A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N.Engl.J.Med. 307: 913−916, 1982
- Veronesi U.,, Adamus J., Bandiera D. C et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities|| Cancen (Philad)/. 1982. Vol.49. — P. 2420−2430
- Veronesi U,, Adamus J., Bandiera D. C et al. Stage I melanoma of the limbs. Immedeate versus delayed node dissection|| Tumor I980.-Vol. 66. — P. 373 379/
- Voit C., Mayer T., Kron M., Schoengen A., Sterry W., Weber L., Proebstle T.M. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients//Cancer. 2000.V.90.N3. P. 186−193.
- Wagner JD, Schauwecker D, Davidson D, et al. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in earlystage cutaneous melanoma. Cancer. 2005−104:570−579.
- Wagner JD, Schauwecker D, Davidson D, et al. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J Clin Oncol. 1999−17:1508−1515.
- Wagner JD, Schauwecker DS, Davidson D, Wenck S, Jung SH, Hutchins G. FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. J Surg Oncol. 2001−77:237−242.
- Walker F, Nicola N, Metcalf et al: Hierarchal down regulation of hematoporetic growth factor receptors. Cell 43: 269−276, 1985
- Wanebo H.J., Woodruff J., Fortner J.G. Malignant melanoma of the axtremities. A clinicopathologic study using levels of invasion (microstage)// Cancer. 1975. V. 220. P. 666−676.
- Wilhelm AJ, Mijnhout GS, Franssen EJF. Radiopharmaceuticals in sentinel lymph-node detection: an overview. Eur J Nucl Med. 1999−26(suppl):S36-S42.
- Wong SL, Brady MS, Busam KJ, Coit DG. Results of sentinel lymph ¦ «node biopsy in patients with thin melanoma. Ann Surg Oncol 2006−13(3):302−9.
- Wong J, Cagle L, Morton D. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 1991 -214(5):637—41.
- Wong SL, Kattan MW, McMasters KM, Coit DG. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol 2005−12(4):282−8.
- Woods JE, Soule EH, Creagan ET. Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg 1983−198(l):63−4.
- Wright BE, Scheri RP, Ye X, et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg. 2008−143(9):892−899- discussion 899−900.
- Wrightson W.R., Wong S.L., Edwards M.J., Celia Chao, Reintgen D.S., Ross M, Noyes R.D., Vicki Viar, RN, MSN, Cerrito P.B. and Rtlly M. McMasters.
- Complicaions associated with sentinel lymph node biopsy for melanoma. Annals of Surgical Oncology, 2003: 10: 676−680.
- Wrone D.A., Tanabe K.K., Cosimi A.B., Gadd M.A., Souba W.W., Sober A.J. Lymphedema after Sentinel Lymph Node Biopsy for Cutaneous Melanoma a Report of 5 cases. Arch Dermatol. 2000- 136: 511−514
- Yock DH. Magnetic Resonance Imaging of CNS. Mosby Yearbook 1995.
- Yoshida Y, Adachi K, Nakashima K, Yamane T, Yamamoto O. Difficulty to identify sentinel lymph nodes with computed tomography-lymphography in patients with cutaneous melanoma. Acta Derm Venereol. 2011 Jun-91(4):465−6.
- Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer. 1999−86:617−627.